z-logo
open-access-imgOpen Access
Hubungan Antara Kepatuhan Minum Obat (MMAS-8) Dan Kualitas Hidup (WHOQOL-BREF) Penderita Tuberkulosis Di Puskesmas Di Kota Bandung
Author(s) -
Dizky Ramadani Putri Papeo,
Maria Immaculata,
Iis Rukmawati
Publication year - 2021
Publication title -
indonesian journal of pharmaceutical education
Language(s) - English
Resource type - Journals
ISSN - 2775-3670
DOI - 10.37311/ijpe.v1i2.11143
Subject(s) - medicine , tuberculosis , medication adherence , cross sectional study , quality of life (healthcare) , disease , physical therapy , family medicine , nursing , pathology
Backgroumd: Tuberculosis (TB) is an infectious disease which is until now has not been able to be threated, i.e., because of patient non-adherence in taking anti-tuberculosis drug (ATD) Objective: The objective of this research is  to study the relationship between patients adherence in taking ATD determined by MMAS-8 questionnaire with QoL of patient determined by WHOQOL questionnaire. Method: Tuberculosis patients who undergo treatment for at least 4 weeks are the subjects in this study. This study was conducted by a cross-sectional method using the MMAS-8 and WHOQOL-BREF questionnaire of tuberculosis patients at Ibrahim Adjiand Gumuruh primary health care during March - August 2018. Result: Based on MMAS-8 questionnaire filled out by 75 patients, there was 69% of high adherence, 15% moderate,  and 16% has low adherence in taking ATD. Of the 6 characteristic factors (i.e., age, sex, occupation, income, education and length of treatment), only gender (p0.01) and occupation (p0.03) factors that influence the patient adherence significantly. Based on MMAS-8 and WHOQOL-BREF questionnaire analyses, there is only psychological health aspect (domain two) that have a significant (p = 0.01) correlated with patient adherence. Conclusion: Based on the results,the psychological health of tuberculosis patients play an important role in patient adherence. 

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here